CVP BioSpain sponsor´s 2023, one of the Europe´s largest events

26/09/2023

---

From September 26th to 28th, Barcelona, a hub of healthcare innovation in Europe, will host BIOSPAIN The vibrant city of Barcelona... Read More

Artax Biopharma Announces Positive Phase 1 Results for AX-158

07/06/2023

---

Aleta Biotherapeutics Granted MHRA Clinical Trial Authorization for Biologic CAR T-Cell Engager ALETA-001. Aleta’s lead program, ALETA-001 has clinical support from... Read More

Minoryx gains FDA approval to patients with cALD

31/05/2023

---

Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy US trial with leriglitazone to... Read More

ARTHEx Biotech Announces Closing of €42 M Series B Financing

03/05/2023

---

ARTHEx Biotech Announces Closing of €42 M Series B Financing to Advance ATX-01, its Novel Treatment for Myotonic Dystrophy Type 1... Read More

Minoryx presents positive interim results from NEXUS registration study

25/04/2023

---

Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD) Initial evidence... Read More

Dr. Robert Armstrong joins as new partner and Columbus opens Boston office

27/03/2023

---

Columbus Venture Partners opens an office in Boston with the addition of Dr. Robert Armstrong as a new partner of the... Read More

Integra Therapeutics acquires CRISPR licence from CIC nanoGUNE

04/01/2023

---

2.6 billion-year-old ancestors of the CRISPR gene-editing tool are resurrected An international study led by Spanish scientists has deciphered the origin... Read More